A Danish study reveals a significant link between low-dose aspirin use and higher anemia rates among older adults.

Bayer's shares plunged to a 20-year low Tuesday after the German chemicals giant cut its earnings outlook and posted a worse-than-expected loss on woes related to its troubled agrochemicals division.

The problems for Bayer, the maker of Aspirin, looked set to continue in 2025 with chief financial officer Wolfgang Nickl warning of a “muted outlook” next year, “with likely declining ...